Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis - Concepedia

Concepedia

Publication | Closed Access

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

151

Citations

24

References

2020

Year

Priscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen, Sara M. Tolaney, Nancy U. Lin, Nancy Wang, Ugonma Chukwueke, Michael White, Naema Nayyar, Albert Kim,

Nature Medicine

Open-label Phase 2MedicineLeptomeningeal CarcinomatosisClinical TrialsPathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyHealth Sciences

References

	Year	Citations

Page 1

Page 1